LGND logo

LGND Working capital

annual working capital:

$294.45M+$73.80M(+33.45%)
December 31, 2024

Summary

  • As of today (May 25, 2025), LGND annual working capital is $294.45 million, with the most recent change of +$73.80 million (+33.45%) on December 31, 2024.
  • During the last 3 years, LGND annual working capital has fallen by -$128.64 million (-30.40%).
  • LGND annual working capital is now -73.39% below its all-time high of $1.11 billion, reached on December 31, 2019.

Performance

LGND Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

quarterly working capital:

$250.63M-$43.81M(-14.88%)
March 31, 2025

Summary

  • As of today (May 25, 2025), LGND quarterly working capital is $250.63 million, with the most recent change of -$43.81 million (-14.88%) on March 31, 2025.
  • Over the past year, LGND quarterly working capital has dropped by -$100.46 million (-28.61%).
  • LGND quarterly working capital is now -81.85% below its all-time high of $1.38 billion, reached on March 31, 2019.

Performance

LGND quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

LGND Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+33.5%-28.6%
3 y3 years-30.4%+7.3%
5 y5 years-73.4%-69.1%

LGND Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-30.4%+78.7%-28.6%+230.1%
5 y5-year-73.4%+78.7%-70.0%+230.1%
alltimeall time-73.4%+388.0%-81.8%+254.8%

LGND Working capital History

DateAnnualQuarterly
Mar 2025
-
$250.63M(-14.9%)
Dec 2024
$294.45M(+33.4%)
$294.45M(+3.5%)
Sep 2024
-
$284.62M(-3.1%)
Jun 2024
-
$293.69M(-16.3%)
Mar 2024
-
$351.10M(+59.1%)
Dec 2023
$220.65M(+33.9%)
$220.65M(-7.4%)
Sep 2023
-
$238.27M(-3.7%)
Jun 2023
-
$247.32M(+7.9%)
Mar 2023
-
$229.27M(+39.1%)
Dec 2022
$164.79M(-61.1%)
$164.79M(+93.4%)
Sep 2022
-
$85.19M(+12.2%)
Jun 2022
-
$75.93M(-67.5%)
Mar 2022
-
$233.49M(-44.8%)
Dec 2021
$423.09M(+5.7%)
$423.09M(+6.9%)
Sep 2021
-
$395.79M(+10.4%)
Jun 2021
-
$358.40M(+4.9%)
Mar 2021
-
$341.62M(-14.7%)
Dec 2020
$400.45M(-63.8%)
$400.45M(-50.9%)
Sep 2020
-
$815.44M(-2.3%)
Jun 2020
-
$834.36M(+3.0%)
Mar 2020
-
$810.29M(-26.8%)
Dec 2019
$1.11B(+40.4%)
$1.11B(-3.6%)
Sep 2019
-
$1.15B(-13.9%)
Jun 2019
-
$1.33B(-3.5%)
Mar 2019
-
$1.38B(+75.2%)
Dec 2018
$788.29M(<-9900.0%)
$788.29M(-17.2%)
Sep 2018
-
$951.88M(+12.3%)
Jun 2018
-
$847.62M(+730.4%)
Mar 2018
-
$102.07M(-5626.4%)
Dec 2017
-$1.85M(-97.1%)
-$1.85M(-75.3%)
Sep 2017
-
-$7.48M(-73.9%)
Jun 2017
-
-$28.66M(-45.2%)
Mar 2017
-
-$52.29M(-18.4%)
Dec 2016
-$64.08M(+690.2%)
-$64.08M(-25.0%)
Sep 2016
-
-$85.44M(-8.9%)
Jun 2016
-
-$93.78M(-177.6%)
Mar 2016
-
$120.82M(-1589.9%)
Dec 2015
-$8.11M(-105.0%)
-$8.11M(-104.2%)
Sep 2015
-
$194.07M(+8.6%)
Jun 2015
-
$178.78M(+3.0%)
Mar 2015
-
$173.56M(+6.9%)
Dec 2014
$162.38M(-4101.5%)
$162.38M(-9.8%)
Sep 2014
-
$180.09M(+1707.4%)
Jun 2014
-
$9.96M(-19.6%)
Mar 2014
-
$12.40M(-405.5%)
Dec 2013
-$4.06M(-65.1%)
-$4.06M(-74.4%)
Sep 2013
-
-$15.83M(-12.1%)
Jun 2013
-
-$18.00M(+17.8%)
Mar 2013
-
-$15.28M(+31.5%)
Dec 2012
-$11.62M(+1.8%)
-$11.62M(-6.7%)
Sep 2012
-
-$12.45M(+33.5%)
Jun 2012
-
-$9.32M(+154.6%)
Mar 2012
-
-$3.66M(-67.9%)
Dec 2011
-$11.41M(-423.2%)
-$11.41M(-27.0%)
Sep 2011
-
-$15.64M(+10.3%)
Jun 2011
-
-$14.18M(+6.8%)
Mar 2011
-
-$13.27M(-475.9%)
Dec 2010
$3.53M(-77.9%)
$3.53M(-353.5%)
Sep 2010
-
-$1.39M(+610.7%)
Jun 2010
-
-$196.00K(-102.2%)
Mar 2010
-
$8.95M(-44.0%)
Dec 2009
$15.99M
$15.99M(+133.6%)
DateAnnualQuarterly
Sep 2009
-
$6.85M(-67.8%)
Jun 2009
-
$21.27M(+43.6%)
Mar 2009
-
$14.81M(-36.5%)
Dec 2008
$23.32M(-60.5%)
$23.32M(-32.0%)
Sep 2008
-
$34.26M(-33.5%)
Jun 2008
-
$51.50M(-10.6%)
Mar 2008
-
$57.59M(-2.4%)
Dec 2007
$58.98M(-8.9%)
$58.98M(+5.4%)
Sep 2007
-
$55.94M(-12.8%)
Jun 2007
-
$64.13M(-26.7%)
Mar 2007
-
$87.45M(+35.1%)
Dec 2006
$64.75M(-163.3%)
$64.75M(-140.0%)
Sep 2006
-
-$161.89M(+4.8%)
Jun 2006
-
-$154.51M(+7.5%)
Mar 2006
-
-$143.69M(+40.5%)
Dec 2005
-$102.24M(+110.8%)
-$102.24M(-4.3%)
Sep 2005
-
-$106.89M(+1.9%)
Jun 2005
-
-$104.94M(+24.2%)
Mar 2005
-
-$84.52M(+74.2%)
Dec 2004
-$48.51M(+186.5%)
-$48.51M(-190.2%)
Sep 2004
-
$53.80M(-6.2%)
Jun 2004
-
$57.34M(-15.2%)
Mar 2004
-
$67.64M(-499.6%)
Dec 2003
-$16.93M(-131.8%)
-$16.93M(-128.4%)
Sep 2003
-
$59.57M(+173.0%)
Jun 2003
-
$21.82M(-13.4%)
Mar 2003
-
$25.19M(-52.7%)
Dec 2002
$53.22M(+143.6%)
$53.22M(+157.6%)
Sep 2002
-
$20.66M(-30.1%)
Jun 2002
-
$29.54M(-208.7%)
Mar 2002
-
-$27.16M(-224.3%)
Dec 2001
$21.85M(+34.6%)
$21.85M(-19.1%)
Sep 2001
-
$27.00M(-16.0%)
Jun 2001
-
$32.13M(-7.6%)
Mar 2001
-
$34.76M(+114.1%)
Dec 2000
$16.23M(-54.9%)
$16.23M(-24.8%)
Sep 2000
-
$21.58M(-30.7%)
Jun 2000
-
$31.13M(-13.6%)
Mar 2000
-
$36.02M(+0.1%)
Dec 1999
$36.00M(-29.5%)
$36.00M(+1.4%)
Sep 1999
-
$35.50M(+51.7%)
Jun 1999
-
$23.40M(-38.9%)
Mar 1999
-
$38.30M(-25.0%)
Dec 1998
$51.10M(-18.1%)
$51.10M(+87.2%)
Sep 1998
-
$27.30M(-16.3%)
Jun 1998
-
$32.60M(-33.9%)
Mar 1998
-
$49.30M(-21.0%)
Dec 1997
$62.40M(-12.8%)
$62.40M(+46.5%)
Sep 1997
-
$42.60M(-17.0%)
Jun 1997
-
$51.30M(-18.4%)
Mar 1997
-
$62.90M(-12.2%)
Dec 1996
$71.60M(+25.0%)
$71.60M(+79.9%)
Sep 1996
-
$39.80M(-15.1%)
Jun 1996
-
$46.90M(-14.7%)
Mar 1996
-
$55.00M(-4.0%)
Dec 1995
$57.30M(+71.0%)
$57.30M(-9.2%)
Sep 1995
-
$63.10M(+92.4%)
Mar 1995
-
$32.80M(-2.1%)
Dec 1994
$33.50M
$33.50M(-15.6%)
Sep 1994
-
$39.70M(+51.5%)
Jun 1994
-
$26.20M(-21.8%)
Mar 1994
-
$33.50M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual working capital?
  • What is the all time high annual working capital for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual working capital year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly working capital?
  • What is the all time high quarterly working capital for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly working capital year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual working capital?

The current annual working capital of LGND is $294.45M

What is the all time high annual working capital for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual working capital is $1.11B

What is Ligand Pharmaceuticals Incorporated annual working capital year-on-year change?

Over the past year, LGND annual working capital has changed by +$73.80M (+33.45%)

What is Ligand Pharmaceuticals Incorporated quarterly working capital?

The current quarterly working capital of LGND is $250.63M

What is the all time high quarterly working capital for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly working capital is $1.38B

What is Ligand Pharmaceuticals Incorporated quarterly working capital year-on-year change?

Over the past year, LGND quarterly working capital has changed by -$100.46M (-28.61%)
On this page